G6PD (Qualitative) Blood Test in Karachi at Dr. Essa Lab

G6PD (Qualitative) at Dr. Essa Lab

The G6PD (Qualitative) test is a specialized laboratory investigation designed to screen for Glucose-6-Phosphate Dehydrogenase (G6PD) enzyme deficiency. G6PD is a vital cytosolic enzyme present in all human cells, but it plays an exceptionally critical role in red blood cells (erythrocytes). This enzyme catalyzes the first step in the pentose phosphate pathway, converting glucose-6-phosphate into 6-phosphoglucono-D-lactone, a process that reduces nicotinamide adenine dinucleotide phosphate (NADP) to NADPH. In red blood cells, NADPH is the sole source of reducing power required to maintain glutathione in its reduced state. Reduced glutathione acts as a primary antioxidant shield, neutralizing reactive oxygen species (ROS) and protecting the erythrocyte membrane and hemoglobin from oxidative damage.

When an individual has a G6PD deficiency, their red blood cells are highly susceptible to oxidative stress. Exposure to certain medications, infections, or specific dietary items can trigger the rapid destruction of these vulnerable red blood cells, leading to acute hemolytic anemia. The G6PD (Qualitative) screening test at Dr. Essa Lab is a rapid, highly reliable method used to determine whether a patient has adequate levels of this protective enzyme or if they suffer from a deficiency. By identifying this hereditary condition early, healthcare providers can guide patients on avoiding specific triggers, thereby preventing life-threatening hemolytic crises and ensuring safe clinical management.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure the clinical accuracy of the G6PD (Qualitative) test results. Patients should adhere to the following preparation guidelines:

• No Fasting Required: Fasting is generally not necessary for this blood test. You may eat and drink normally prior to your appointment.
• Disclose Recent Transfusions: It is critical to inform the laboratory staff if you have received a blood transfusion within the last 3 months. Transfused blood contains normal G6PD levels, which can temporarily mask a deficiency and lead to a false-normal result.
• Timing Post-Hemolysis: If you have recently experienced an acute hemolytic episode, testing should ideally be delayed. During hemolysis, older, enzyme-deficient red blood cells are destroyed first, leaving behind younger reticulocytes that naturally contain higher levels of G6PD. Testing during or immediately after a crisis can produce a false-normal result.
• Medication History: Provide a complete list of all medications, over-the-counter drugs, and herbal supplements you are currently taking, as some substances can interfere with the test or may have triggered a recent hemolytic event.

During the Procedure

The G6PD (Qualitative) test is performed using a standard venipuncture technique. The procedure is quick, safe, and conducted by experienced phlebotomists at Dr. Essa Lab:

• Sanitization: The phlebotomist will locate a suitable vein, typically in the inner crease of your elbow, and cleanse the area thoroughly with an antiseptic swab.
• Sample Collection: A sterile, single-use needle is gently inserted into the vein to draw a small volume of blood into a lavender-top (EDTA) or green-top (heparin) collection tube.
• Post-Collection Care: Once the sample is collected, the needle is removed, and gentle pressure is applied to the puncture site with a sterile cotton ball to stop any minor bleeding. A small adhesive bandage is then applied.
• Duration and Sensation: The entire blood collection process takes less than five minutes. You may feel a brief, mild pinch or stinging sensation as the needle enters the skin.

When is a G6PD (Qualitative) Performed?

Investigation of Neonatal Jaundice

Physicians frequently request a G6PD (Qualitative) test for newborns who present with severe, prolonged, or early-onset jaundice within the first 24 to 48 hours of life. In infants with G6PD deficiency, the rapid breakdown of red blood cells leads to an excess of indirect bilirubin. If left undiagnosed and untreated, severe hyperbilirubinemia can cross the blood-brain barrier, causing kernicterus, a permanent and devastating form of brain damage. Early screening allows pediatricians to initiate timely phototherapy or exchange transfusions.

Prior to Initiating Oxidative Drug Therapy

Before prescribing medications known to induce oxidative stress, clinicians routinely order a G6PD screening. Common offending agents include antimalarial drugs like primaquine and pamaquine, sulfones such as dapsone, sulfonamide antibiotics, nitrofurantoin, and rasburicase. Administering these drugs to a G6PD-deficient individual can precipitate a sudden and severe hemolytic crisis. Performing this qualitative test beforehand ensures patient safety by allowing doctors to select alternative, non-oxidative therapies.

Unexplained Acute Hemolytic Anemia

When a patient presents with sudden clinical signs of hemolysis—such as rapid-onset fatigue, pallor, shortness of breath, tachycardia, and dark, tea-colored urine—a G6PD test is indicated. These symptoms often manifest shortly after an acute viral or bacterial infection, which is the most common trigger for hemolysis in G6PD-deficient individuals. The test helps confirm whether an underlying enzyme deficiency is the primary cause of the accelerated red blood cell destruction.

Family History of G6PD Deficiency

Because G6PD deficiency is an X-linked recessive genetic disorder, it primarily affects males, while females are typically asymptomatic carriers. If a family has a known history of G6PD deficiency, screening is highly recommended for male infants and maternal relatives. Identifying the deficiency early in life empowers families to implement dietary and environmental precautions, preventing accidental exposure to oxidative triggers.

Evaluation after Exposure to Environmental Triggers

Physicians request this test when a patient develops sudden hemolytic symptoms after consuming fava beans (a condition known as favism) or after inhaling or ingesting naphthalene (found in mothballs). Favism is a classic manifestation of G6PD deficiency, driven by the oxidative compounds vicine and convicine present in fava beans. Confirming a deficiency in these patients is vital to establishing a lifelong avoidance strategy to prevent future recurrences.

What Does a G6PD (Qualitative) Detect?

The G6PD (Qualitative) test is designed to detect and evaluate several critical clinical parameters and risks, including:

• Adequate or deficient levels of G6PD enzyme activity in erythrocytes.
• Severe G6PD enzyme deficiency characteristic of Class I and Class II variants.
• Moderate G6PD enzyme deficiency associated with Class III variants.
• Increased susceptibility to drug-induced intravascular hemolysis.
• Risk of developing favism upon consumption of broad beans (fava beans).
• Vulnerability to infection-induced hemolytic episodes.
• Underlying cause of neonatal hyperbilirubinemia and pathological jaundice.
• Potential carrier status in females (though quantitative testing may be needed for definitive carrier detection).
• Contraindications for the safe administration of antimalarial therapies like primaquine.
• Contraindications for the use of dapsone and other sulfone medications.
• Contraindications for the clinical use of rasburicase in hyperuricemia management.
• Risk of hemolysis associated with high-dose intravenous Vitamin C therapy.
• Presence of Heinz bodies (denatured hemoglobin) in red blood cells under oxidative stress.
• Underlying etiology of chronic nonspherocytic hemolytic anemia (CNSHA).
• Need for confirmatory quantitative G6PD enzyme assays.
• Confounding factors such as recent blood transfusions that may skew diagnostic results.
• Impact of high reticulocyte counts on masking an underlying enzyme deficiency.
• Need for genetic counseling in families with a documented history of the mutation.
• Vulnerability to hemolysis from exposure to industrial chemical triggers or naphthalene.
• Overall integrity and oxidative defense capacity of the patient’s red blood cells.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is committed to providing rapid, highly accurate diagnostic results to facilitate timely clinical decisions. The turnaround time for a G6PD (Qualitative) blood test is typically within 12 to 24 hours from the time of sample collection. Once the analysis is complete, the report undergoes a rigorous multi-level verification process by qualified pathologists to ensure absolute accuracy.

Patients can conveniently access their diagnostic reports online through the official Dr. Essa Lab website portal or via their dedicated mobile application. To retrieve your digital report, simply enter your unique Lab ID and password provided on your receipt. Physical copies of the reports are also available for collection at any of the numerous Dr. Essa Lab collection centers located across Karachi and other major cities.

G6PD (Qualitative) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
G6PD Enzyme Activity	Normal / Adequate activity (No deficiency detected)	Deficient / Reduced activity (Deficiency detected)
Red Blood Cell Lifespan	Normal (approximately 120 days)	Significantly shortened during oxidative stress
Serum Bilirubin Levels	Total: 0.2–1.2 mg/dL; Indirect: <0.8 mg/dL	Elevated indirect bilirubin (hemolytic jaundice)
Hemoglobin and Hematocrit	Within normal physiological limits	Decreased (indicative of acute or chronic anemia)
Reticulocyte Count	0.5% to 2.5% of total RBCs	Elevated (compensatory bone marrow response)
Urine Color and Hemoglobin	Clear, straw-colored; negative for hemoglobin	Dark, tea-colored; positive for hemoglobinuria
Peripheral Blood Smear	Normocytic, normochromic erythrocytes	Presence of Heinz bodies, bite cells, and blister cells

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for G6PD (Qualitative)?

• Experienced healthcare professionals ensuring accurate sample collection and analysis.
• Patient-focused care designed to make your diagnostic experience comfortable and stress-free.
• Quality diagnostic services adhering to international laboratory standards.
• Professional reporting verified by qualified consultant pathologists.
• Modern diagnostic approach utilizing state-of-the-art laboratory equipment.
• Comfortable environment across all collection centers and main diagnostic hubs.
• Convenient locations throughout Karachi, making diagnostic services highly accessible.
• Commitment to accurate diagnosis to help guide your clinical treatment effectively.